MedReleaf is one of less than four dozen licensed producers and retailers of medical cannabis products in Canada. The company was founded just four years ago, and it focuses on supplying dried cannabis, cannabis oils, and cannabis oil capsules to qualified medical patients in Canada.
Tag Archives: Canada
A former steel town in Pennsylvania has turned to medical marijuana for an economic boost, taking direction from a Canadian town that made a similar move.
OTTAWA, Ont., June 23, 2017 /Weed Wire/ — I welcome the publication of the “Lower-Risk Cannabis Use Guidelines” today in the American Journal of Public Health. The Canadian Institutes of Health Research supported the development of these Guidelines through funding provided to the Canadian Research Initiative in Substance Misuse.
Canada’s recreational cannabis legalization is planned for a rollout in July 2018, but provinces and territories are in charge of drafting and establishing jurisdiction-specific rules, so they’ve been working hard to create rules that fall within the country’s legalization framework.
FREDERICTON, N.B., June 21, 2017 /Weed Wire/ – A proposed provincial model for the legalization of recreational cannabis was outlined today in an interim report released by a government working group.
According to a press release from Health Canada in late May, big changes are coming to the country’s medical cannabis program.
John Tory said Tuesday that he believes the possession of small amounts of marijuana for personal use should have been decriminalized “years ago,” but that Toronto police should continue to target illegal dispensaries across the city.
Canadian cannabis decriminalization has earned the support of Toronto’s Board of Health. On June 12, 2017, the board voted unanimously to request that the Government of Canada immediately decriminalize the possession of cannabis for personal use.
On June 12, 2017, ASTM International, an international voluntary consensus standards organization, announced that it had signed a Memorandum of Understanding with the Foundation of Cannabis Unified Standards, indicating that the two organizations will collaborate in developing cannabis standards for the legal cannabis industry.
Oh, how the mighty have fallen. Shares of Canopy Growth Corp. have dropped by over $6 a share, or 47.5%, since the middle of February.
There is so much Canadian cannabis investment money right now that it is cascading down into the United States and Canadian investors are easily outbidding domestic acquirers.
Canadian marijuana stocks have been on a punishing slide for three straight months despite a temporary blip of investor fever in April that sent share prices soaring to record highs as Ottawa tabled legislation to legalize pot.
On June 2, 2017, Alberta, one of Canada’s western provinces, announced that it is seeking input from Albertans on the province’s recreational marijuana rollout.
EDMONTON, Alberta, June 2, 2017 /Weed Wire/ — The survey, along with a series of stakeholder engagements, will help guide how Alberta will adapt to proposed federal legislation that would legalize cannabis by July 2018. Albertans are asked to visit alberta.ca/cannabis to learn more about cannabis legalization and participate in the survey, which will run until July 31, 2017.
How about another cannabis company to spark up your interest? Newstrike Ltd. is Canada’s newest pot stock that will be hitting the TSX Venture Exchange this Thursday.
There’s no breathalyzer for marijuana, so catching high drivers is the job of Drug Recognition Evaluators. See how it’s done in Canada.
On Monday, May 29, 2017, Tweed Inc., a wholly owned subsidiary of Canopy Growth Corporation (TSX:WEED), was evacuated following a small morning fire at the Hershey Chocolate Factory’s former Visitor Center, which the medical marijuana company is currently renovating.
There are a handful of legitimate cultivators at this time, and an intriguing small-cap company is Aphria Inc. This marijuana stock is currently trading around $4.00, with a market cap of $579.3 million.
OTTAWA, Ontario, May 26, 2017 /Weed Wire/ — Health Canada is introducing several improvements to its medical cannabis program that aim to streamline the application process for issuing production licenses and enable increased production under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
LOS ANGELES, May 25, 2017 /Weed Wire/ — Agritek Holdings, Inc. (OTCQB: AGTK) (www.AgritekHoldings.com) today announced that the Company has executed a land purchase agreement to purchase a “420 Style” resort and estate property approximately one hour outside of Quebec City, Canada.
Prime Minister Justin Trudeau promised marijuana legalization in his 2015 campaign, and he’s making good on that promise. However, Canadian executives, aren’t happy.
On May 19, 2017, Beleave Inc. (CNX:BE) announced that its subsidiary, First Access Medical Inc., had been awarded a cultivation license from Health Canada, prompting the Canadian cannabis stock to rise 7.62% on Friday.
The most controversial thing about Canada’s move to legalize marijuana nationwide may be setting the minimum age for use at 18.
KELOWNA, British Columbia, May 18, 2017 /Weed Wire/ – Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) is one of five companies featured on a special BTV episode exploring burgeoning cannabis enterprises.
Countries around the globe are embracing legal medicinal or recreational cannabis, and the industry is reacting accordingly.
While investors holding for the past year have still made a positive return, there may not be much room left for marijuana companies’ shares to run higher.
Canada’s Finance Minister Bill Morneau is ready to talk Canadian cannabis taxes with the country’s provinces. On May 15, 2017, during a House of Commons meeting for the Standing Committee on Finance, Morneau addressed the Budget Measure Implementation Act and closed his opening remarks with a note on cannabis taxes.
NANAIMO, British Columbia, May 15, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today unveiled a new product categorization system that simplifies the process of choosing medical cannabis products for patients in Canada.
A major Canadian medical marijuana player, Canopy Growth is a producer and retailer of medical cannabis products and oils in our neighbor to the north. It’s also the only other marijuana stock other than GW Pharmaceuticals to bear a $1 billion valuation.
Chile has become the first country in Latin America to sell cannabis medicines at pharmacies. The pilot program was launched Wednesday.
With multiple companies showing returns of more than 100%, you have what has turned into one of the more attractive sectors for investors in 2017. But is this the right move? Are marijuana stocks worth it? Most importantly, is now the time to invest in marijuana stocks?
NANAIMO, British Columbia, May 4, 2017 /Weed Wire/ – Tilray, a global leader in medical cannabis research and production, today announced that Tilray cannabinoid products have arrived and are cleared for distribution in European Union member state Cyprus after the company received necessary approvals in Canada and Cyprus to export cannabinoid formulations for patients in Cyprus.
There has been a cannabis shipment in Australia, as Canada legally imported medicinal cannabis to Melbourne and Perth.
After an Ottawa ban on celebrity endorsements of marijuana products, Snoop Dogg will not be able to explicitly promote Canopy’s Tweed-branded products.
On April 25, 2017, ASTM International, an international voluntary consensus standards organization, announced that its board of directors had approved the formation of a cannabis committee, signaling the professional development of global standards for the legal cannabis industry.
W. CONSHOHOCKEN,Penn., April 25, 2017 /Weed Wire/ — ASTM International, one of the world’s leading standards organizations, announced today that its board of directors has approved the formation of a committee on cannabis (D37). The organization also announced that the committee will hold its first official meeting June 11-12 in Toronto.
Aphria Inc (TSE:APH) is now the front-runner in the race to hit the billion-dollar valuation mark.
Three Canadian medical cannabis companies, which have been expanding their growth operations like crazy over the past couple of quarters, could be in line for significant sales growth if Trudeau’s legislation passes.
Prime Minister Justin Trudeau recently introduced legislation to legalize use of recreational marijuana in Canada. While legalization should help Canadian marijuana providers, could it also provide a boost to U.S. marijuana stocks?
There is an opportunity for excess profits in the Canadian marijuana industry as the market is now in a position to expand at a very high rate, as Canadians have received confirmation that the potential legalization will become a reality.
VICTORIA, British Columbia, April 17, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH) (“Emerald” or the “Company”) today announced the launch of its CBD-25< and CBD-50 medical cannabis oils containing 25mg and 50mg of CBD per ml.
CityNews reporter Shauna Hunt takes a look at the impact marijuana legalization will have on the city of Toronto.
As Canada heads toward legalization of marijuana, Alberta producer Aurora Cannabis is focused on expansion with ambitions to raise a $160-million “war chest” from investors who are anxious to profit from what is expected to be a multibillion industry.
OTTAWA, Canada, April 13, 2017 /Weed Wire/ — The focus of government legislation and regulation in the area of cannabis must be to protect and enhance safety. While the Canadian Pharmacists Association (CPhA) is pleased that today’s federal legislation maintains a separate stream for medical cannabis, we are concerned and disappointed that the legislation fails to enhance patient safety by providing appropriate clinical oversight in the management and dispensing of medical cannabis in Canada.
On Thursday, April 13, 2017, Canada made headlines with its official introduction of legislation to legalize recreational cannabis in the country by July 2018. While the country’s announcement has major national and international implications, cannabis stocks in Canada took a downturn upon hearing the news.
On April 13, 2017, the Minister of Justice and Attorney General of Canada Jody Wilson-Raybould introduced legislation to legalize recreational cannabis in Canada by July 2018.
OTTAWA, Ontario, April 13, 2017 /Weed Wire/ — Cannabis Canada, the leading organization of companies that hold Health Canada licenses to cultivate and sell medical cannabis, welcomes the legislation tabled today by the Government of Canada to legalize, regulate, and restrict access to cannabis.
OTTAWA, Canada, April 13, 2017 /Weed Wire/ — The current approach to cannabis does not work. It has allowed criminals and organized crime to profit, while failing to keep cannabis out of the hands of Canadian youth. In many cases, it is easier for our kids to buy cannabis than cigarettes.
Insiders with two of Canada’s largest marijuana companies are cashing in on the industry’s reefer madness before the country introduces its plans for legalized recreational pot.
Aphria Inc. has been soaring since its graduation to the TSX last month. The company now has a $1.1 billion market cap and could pass Canopy Growth Corp. with its $1.74 billion market cap over the next few months. There’s no question Canopy stock has slowed down when compared to its peers like Aphria and Aurora Cannabis Inc